DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
5.71
+0.04 (0.71%)
Jan 17, 2025, 4:00 PM EST - Market closed
DiaMedica Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 17, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 244 | 108 | 42 | 99 | 190 | 58 | |
| Market Cap Growth | 82.94% | 157.97% | -57.63% | -48.10% | 226.30% | 67.36% | |
| Enterprise Value | 194 | 52 | 6 | 51 | 160 | 49 | |
| Last Close Price | 5.71 | 2.84 | 1.58 | 3.73 | 10.14 | 4.85 | |
| PB Ratio | 5.09 | 2.11 | 1.31 | 2.24 | 7.30 | 7.65 | |
| P/TBV Ratio | 3.73 | 2.11 | 1.31 | 2.24 | 7.30 | 7.65 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 | |
| Quick Ratio | 11.75 | 19.12 | 15.49 | 29.69 | 13.73 | 6.60 | |
| Current Ratio | 11.81 | 19.27 | 15.61 | 29.82 | 13.77 | 6.70 | |
| Return on Equity (ROE) | -41.90% | -46.77% | -36.06% | -38.81% | -73.10% | -86.43% | |
| Return on Assets (ROA) | -27.23% | -30.02% | -21.89% | -23.16% | -42.73% | -52.90% | |
| Return on Capital (ROIC) | -28.87% | -31.74% | -22.92% | -24.30% | -46.79% | -58.33% | |
| Earnings Yield | -8.89% | -17.98% | -32.73% | -13.78% | -6.47% | -18.29% | |
| FCF Yield | -7.98% | -17.40% | -27.74% | -12.45% | -4.86% | -15.63% | |
| Buyback Yield / Dilution | -32.12% | -23.16% | -27.29% | -32.48% | -30.80% | -54.81% | |
| Total Shareholder Return | -32.12% | -23.16% | -27.29% | -32.48% | -30.80% | -54.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.